{"Title": ["Implied Volatility Surging for Acura (ACUR) Stock Options", "Health Care Sector Update for 06/15/2016: ACUR,JAGX,SCYX", "Health Care Sector Update for 06/09/2016: ACUR,JAGX,SCYX", "Egalet (EGLT) Worth Watching: Stock Moves 5.2% Higher", "Health Care Sector Update for 06/16/2015: ACUR,AERI,AAVL", "Impax Rytary FDA Action Date Extended by Three Months - Analyst Blog", "Sector Update: Health Care Shares Sticking Near Even Through Early Trade", "Sector Update: Health Care", "Implied Volatility Surging for Acura (ACUR) Stock Options", "Sector Update: Health-Care Shares Flat in Pre-Market Trade", "Sector Update: Health Care", "Mallinckrodt Beats on Q3 Earnings and Revenues, Ups View - Analyst Blog", "Novartis Settles Litigation Agreement with Acura - Analyst Blog", "Acura Pharma Ends Agreement with Pfizer - Analyst Blog", "Sector Update: Healthcare Shares Mixed in Pre-Market Trade; Pfizer Subsidiary Ends License Deal with Acura", "Sector Update: Healthcare", "Mallinckrodt Acquires Questcor, to Join S&P 500 As Well - Analyst Blog", "Acura Pharmaceuticals, Inc. (ACUR) Looks Good: Stock Adds 5.1% in Session - Tale of the Tape", "Acura Confirms $10M Loan Agreement - Analyst Blog", "Healthcare Stocks Giving Back Morning Rise; Acura Pharma Loses Gains, Flat After Securing $10M in Debt Funding", "Sector Update: Healthcare", "Acura Settles Oxecta Litigation - Analyst Blog", "Acura's Nexafed Doing Well - Analyst Blog", "Acura Pharmaceuticals, Inc Enters Oversold Territory - Tale of the Tape", "Acura Pharmaceuticals, Inc. (ACUR) in Focus: Stock Moves 7.7% Higher - Tale of the Tape", "Supernus, Catalent Collaborate - Analyst Blog", "Actavis Acquires Rights to Antifungal Drug - Analyst Blog", "Market Wrap for Monday, July 1: Stocks Rise, But Finish Off Session Highs", "Market Wrap for Tuesday, March 5: Stocks Rally as Dow Closes at New All-Time High", "Top 10 list of unusual option activity", "Mid-Day Update: Stocks Shake Off Greece Worries to Sit Higher at Session's Half; Commodities Mixed", "US Indexes Gains Despite Greece Worries; Commodities Mixed at the Session's Half", "Setback for Acura Pharma - Analyst Blog"], "Elapsed Time": ["JAN 10, 2017", "JUN 15, 2016", "JUN 9, 2016", "SEP 10, 2015", "JUN 16, 2015", "SEP 18, 2014", "AUG 27, 2014", "AUG 27, 2014", "JAN 10, 2017", "AUG 15, 2014", "AUG 15, 2014", "AUG 13, 2014", "MAY 23, 2014", "APR 11, 2014", "APR 10, 2014", "APR 10, 2014", "AUG 18, 2014", "FEB 18, 2014", "JAN 3, 2014", "DEC 31, 2013", "DEC 31, 2013", "OCT 11, 2013", "SEP 19, 2013", "AUG 29, 2013", "MAR 13, 2014", "AUG 23, 2013", "AUG 8, 2013", "JUL 1, 2013", "MAR 5, 2013", "JUN 24, 2011", "JUN 20, 2011", "JUN 20, 2011", "AUG 27, 2013"], "Published Date": [], "Link": ["https://www.nasdaq.com/articles/implied-volatility-surging-for-acura-acur-stock-options-2017-01-10", "https://www.nasdaq.com/articles/health-care-sector-update-06152016-acurjagxscyx-2016-06-15", "https://www.nasdaq.com/articles/health-care-sector-update-06092016-acurjagxscyx-2016-06-09", "https://www.nasdaq.com/articles/egalet-eglt-worth-watching%3A-stock-moves-5.2-higher-2015-09-10", "https://www.nasdaq.com/articles/health-care-sector-update-06162015-acuraeriaavl-2015-06-16", "https://www.nasdaq.com/articles/impax-rytary-fda-action-date-extended-by-three-months-analyst-blog-2014-09-18", "https://www.nasdaq.com/articles/sector-update-health-care-shares-sticking-near-even-through-early-trade-2014-08-27", "https://www.nasdaq.com/articles/sector-update-health-care-2014-08-27", "https://www.nasdaq.com/articles/implied-volatility-surging-for-acura-acur-stock-options-2017-01-10", "https://www.nasdaq.com/articles/sector-update-health-care-shares-flat-pre-market-trade-2014-08-15", "https://www.nasdaq.com/articles/sector-update-health-care-2014-08-15-0", "https://www.nasdaq.com/articles/mallinckrodt-beats-on-q3-earnings-and-revenues-ups-view-analyst-blog-2014-08-13", "https://www.nasdaq.com/articles/novartis-settles-litigation-agreement-with-acura-analyst-blog-2014-05-23", "https://www.nasdaq.com/articles/acura-pharma-ends-agreement-with-pfizer-analyst-blog-2014-04-11", "https://www.nasdaq.com/articles/sector-update-healthcare-shares-mixed-pre-market-trade-pfizer-subsidiary-ends-license-deal", "https://www.nasdaq.com/articles/sector-update-healthcare-2014-04-10-0", "https://www.nasdaq.com/articles/mallinckrodt-acquires-questcor-to-join-sp-500-as-well-analyst-blog-2014-08-18", "https://www.nasdaq.com/articles/acura-pharmaceuticals-inc.-acur-looks-good%3A-stock-adds-5.1-in-session-tale-of-the-tape", "https://www.nasdaq.com/articles/acura-confirms-%2410m-loan-agreement-analyst-blog-2014-01-03", "https://www.nasdaq.com/articles/healthcare-stocks-giving-back-morning-rise-acura-pharma-loses-gains-flat-after-securing", "https://www.nasdaq.com/articles/sector-update-healthcare-2013-12-31-0", "https://www.nasdaq.com/articles/acura-settles-oxecta-litigation-analyst-blog-2013-10-11", "https://www.nasdaq.com/articles/acuras-nexafed-doing-well-analyst-blog-2013-09-19", "https://www.nasdaq.com/articles/acura-pharmaceuticals-inc-enters-oversold-territory-tale-of-the-tape-2013-08-29", "https://www.nasdaq.com/articles/acura-pharmaceuticals-inc.-acur-in-focus%3A-stock-moves-7.7-higher-tale-of-the-tape-2014-03", "https://www.nasdaq.com/articles/supernus-catalent-collaborate-analyst-blog-2013-08-23", "https://www.nasdaq.com/articles/actavis-acquires-rights-to-antifungal-drug-analyst-blog-2013-08-08", "https://www.nasdaq.com/articles/market-wrap-monday-july-1-stocks-rise-finish-session-highs-2013-07-01", "https://www.nasdaq.com/articles/market-wrap-tuesday-march-5-stocks-rally-dow-closes-new-all-time-high-2013-03-05", "https://www.nasdaq.com/articles/top-10-list-unusual-option-activity-2011-06-24", "https://www.nasdaq.com/articles/mid-day-update-stocks-shake-greece-worries-sit-higher-sessions-half-commodities-mixed-2011", "https://www.nasdaq.com/articles/us-indexes-gains-despite-greece-worries-commodities-mixed-sessions-half-2011-06-20", "https://www.nasdaq.com/articles/setback-for-acura-pharma-analyst-blog-2013-08-27"], "Content": []}